EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 47 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $12,673 | -99.9% | 1,254,733 | +26.0% | 0.33% | +81.2% |
| Q3 2022 | $9,855,000 | +42.1% | 995,474 | +40.6% | 0.18% | +5.2% |
| Q2 2022 | $6,934,000 | +285.0% | 708,223 | +282.9% | 0.17% | +237.3% |
| Q1 2022 | $1,801,000 | +9378.9% | 184,956 | +9419.1% | 0.05% | – |
| Q4 2021 | $19,000 | 0.0% | 1,943 | 0.0% | 0.00% | – |
| Q3 2021 | $19,000 | – | 1,943 | +5151.4% | 0.00% | – |
| Q2 2021 | $0 | – | 37 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |